The protective effects of methyl jasmonate against adriamycin--induced hepatic and renal toxicities
A M Kosoko1, C J Molokwu, E O Farombi
1Drug Metabolism and Toxicology Research Laboratories, Department of Biochemistry, Faculty of Basic Medical Sciences, (IAMRAT), College of Medicine, University of Ibadan, Ibadan, Nigeria.
Abstract:
The aim of the study was to investigate the protective effect of methyl jasmonate (MJ) in adriamycin (ADR) induced hepatic and renal toxicities. 36 BALB/c mice were randomly divided into control, ADR (20 mg/kg), MJ (50 mg/kg) only, MJ (100 mg/kg) only, MJ (50 mg/ kg) + ADR, MJ (100 mg/kg) + ADR groups (n = 6). The 2 doses of MJ was administered for 7 days in MJ only groups, ADR was administered intraperitoneally on the 8th day after pretreatment with the 2 different doses of MJ while ADR was administered on the 8th day only for the ADR only group. The malondialdehyde (MDA), glutathione (GSH), H2O2 generation, superoxide dismutase (SOD), catalase (CAT), glutathione S-transferase (GST), aspartate aminotransferase (AST), alanine aminotransferase (ALT), urea and creatinine in the liver, kidneys and serum samples as applicable were estimated. Tissue MDA, H2O2 generation, and GST activity were markedly elevated while GSH content, CAT and SOD activities were significantly reduced in the tissues when compared to the control (p < 0.05). Pretreatment with MJ ameliorated ADR toxicities, with a significant reduction in serum urea concentration, ALT activity, MDA level, H2O2 generation, GST activity and a significant elevation in GSH content, CAT and SOD activities in the organ tissues. MJ induced significant reduction in MDA level and increase of GSH content in liver and kidney tissues. This study suggests that MJ may play an overall protective effect on ADR-induced toxicities in liver and kidneys and the inhibition of tissue peroxidative damage might contribute to this beneficial effect.
Insights
Methyl jasmonate (MJ) protects against adriamycin (ADR) induced liver and kidney damage by reducing oxidative stress. MJ treatment significantly improved antioxidant levels and reduced markers of toxicity in mice.
Area of Science:
- Biochemistry
- Toxicology
- Pharmacology
Background:
- Adriamycin (ADR) is a potent chemotherapy agent with significant hepatic and renal toxicities.
- Oxidative stress plays a crucial role in ADR-induced organ damage.
- Methyl jasmonate (MJ) is a plant-derived compound with known antioxidant properties.
Purpose of the Study:
- To investigate the protective effects of methyl jasmonate (MJ) against adriamycin (ADR) induced liver and kidney toxicities.
- To evaluate the impact of MJ on oxidative stress markers in ADR-treated mice.
- To determine the optimal dosage of MJ for mitigating ADR-induced organ damage.
Main Methods:
- BALB/c mice were divided into control, ADR, MJ-only, and MJ + ADR groups.
- Mice received varying doses of MJ and/or ADR over an 8-day period.
- Liver, kidney, and serum samples were analyzed for malondialdehyde (MDA), glutathione (GSH), H2O2, superoxide dismutase (SOD), catalase (CAT), glutathione S-transferase (GST), urea, creatinine, AST, and ALT levels.
Main Results:
- ADR treatment significantly increased MDA, H2O2, and GST, while decreasing GSH, CAT, and SOD in liver and kidney tissues.
- MJ pretreatment significantly reduced ADR-induced increases in serum urea, ALT, MDA, H2O2, and GST.
- MJ pretreatment also significantly elevated GSH, CAT, and SOD levels in organ tissues, indicating reduced oxidative stress.
Conclusions:
- Methyl jasmonate (MJ) demonstrates a significant protective effect against adriamycin (ADR)-induced hepatic and renal toxicities.
- The protective mechanism of MJ likely involves the inhibition of tissue peroxidative damage and enhancement of antioxidant defense systems.
- MJ holds potential as a therapeutic agent to mitigate the side effects of ADR chemotherapy.
Related Concept Videos
Drug Toxicity: Dose-Dependent Reactions
Drug Toxicity: Overview
Toxic Reactions: Overview
Toxicity falls into two primary categories: local and systemic.
Local toxicity appears at the exposure site, such as protein denaturation caused by caustic substances.
In contrast, systemic toxicity requires the toxic agent's absorption and distribution,...
Drug Toxicity: Allergic Reactions
Drug Toxicity: Risk factors
Bioactivation and Tissue Toxicity

